Oxford BioMedica PLC (OXBDF)
4.401
0.00 (0.00%)
USD |
OTCM |
May 24, 16:00
Oxford BioMedica Shareholders Equity (Quarterly): 94.28M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 94.28M |
| June 30, 2023 | 217.08M |
| June 30, 2023 | 217.08M |
| December 31, 2022 | 247.67M |
| June 30, 2022 | 269.30M |
| June 30, 2022 | 269.30M |
| December 31, 2021 | 252.84M |
| June 30, 2021 | 183.52M |
| June 30, 2021 | 183.52M |
| December 31, 2020 | 153.65M |
| June 30, 2020 | 133.97M |
| June 30, 2020 | 133.97M |
| December 31, 2019 | 99.16M |
| June 30, 2019 | 101.64M |
| June 30, 2019 | 101.64M |
| December 31, 2018 | 44.08M |
| June 30, 2018 | 40.91M |
| June 30, 2018 | 40.91M |
| December 31, 2017 | 8.306M |
| June 30, 2017 | 14.05M |
| June 30, 2017 | 14.05M |
| December 31, 2016 | 15.50M |
| June 30, 2016 | 12.49M |
| June 30, 2016 | 12.49M |
| December 31, 2015 | 16.14M |
| Date | Value |
|---|---|
| June 30, 2015 | 27.13M |
| June 30, 2015 | 27.13M |
| December 31, 2014 | 35.86M |
| June 30, 2014 | 41.38M |
| June 30, 2014 | 41.38M |
| December 31, 2013 | 14.67M |
| June 30, 2013 | 21.38M |
| June 30, 2013 | 21.38M |
| December 31, 2012 | 31.74M |
| June 30, 2012 | 20.13M |
| June 30, 2012 | 20.13M |
| December 31, 2011 | 27.38M |
| June 30, 2011 | 35.46M |
| December 31, 2010 | 17.91M |
| June 30, 2010 | 27.98M |
| December 31, 2009 | 33.92M |
| June 30, 2009 | 38.46M |
| December 31, 2008 | 34.08M |
| June 30, 2008 | 63.56M |
| December 31, 2007 | 63.42M |
| June 30, 2007 | 75.08M |
| December 31, 2006 | 58.93M |
| June 30, 2006 | 70.91M |
| December 31, 2005 | 80.14M |
| June 30, 2005 | 39.62M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
94.28M
Minimum
Dec 2023
269.30M
Maximum
Jun 2022
177.24M
Average
183.52M
Median
Jun 2021
Shareholders Equity (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 24.38M |
| Biodexa Pharmaceuticals Plc | 5.959M |
| Verona Pharma PLC | 224.99M |
| NuCana PLC | 12.79M |
| Autolus Therapeutics PLC | 582.03M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 321.46M |
| Total Liabilities (Quarterly) | 222.31M |
| Debt to Equity Ratio | 0.5207 |
| Current Ratio | 3.189 |
| Net Debt Paydown Yield | 4.34% |